Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
4.010
-0.100 (-2.43%)
Jun 16, 2026, 4:00 PM EDT - Market closed
Foghorn Therapeutics Employees
Foghorn Therapeutics had 106 employees as of December 31, 2025. The number of employees decreased by 6 or -5.36% compared to the previous year.
Employees
106
Change (1Y)
-6
Growth (1Y)
-5.36%
Revenue / Employee
$266,264
Profits / Employee
-$710,604
Market Cap
236.62M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 106 | -6 | -5.36% |
| Dec 31, 2024 | 112 | -4 | -3.45% |
| Dec 31, 2023 | 116 | -45 | -27.95% |
| Dec 31, 2022 | 161 | 42 | 35.29% |
| Dec 31, 2021 | 119 | 24 | 25.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Cellectis | 229 |
| Humacyte | 184 |
| Fate Therapeutics | 161 |
| Entrada Therapeutics | 152 |
| Adagene | 128 |
| Orchestra BioMed Holdings | 86 |
| InflaRx | 65 |
| Fulcrum Therapeutics | 55 |
FHTX News
- 7 days ago - Foghorn Therapeutics Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 11 days ago - Foghorn Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference 2026 - GlobeNewsWire
- 5 weeks ago - Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences in May - GlobeNewsWire
- 5 weeks ago - Foghorn Therapeutics reports Q1 EPS (29c), consensus (31c) - TheFly
- 5 weeks ago - Foghorn Therapeutics Provides First Quarter 2026 Financial and Corporate Update - GlobeNewsWire
- 5 weeks ago - Foghorn Therapeutics Quarterly report: Q1 2026 - Filings
- 5 weeks ago - Foghorn Therapeutics Earnings release: Q1 2026 - Filings
- 5 weeks ago - Foghorn Therapeutics Slides: Investor presentation - Filings